|
Market Closed -
NYSE
04:00:02 2026-11-02 pm EST
|
5-day change | 1st Jan Change | ||
| 250.81 USD | -0.40% |
|
+3.24% | +44.53% |
| Oct. 28 | Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235 | MT |
| Oct. 27 | Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $279 From $251 | MT |
| Market Cap | 27.59B 24.64B 22.61B 20.56B 38.56B 2,612B 39.32B 270B 109B 1,379B 104B 101B 4,355B | P/E 2026 * |
24.3x | P/E 2027 * | 22.9x |
|---|---|---|---|---|---|
| Enterprise Value | 32.58B 29.09B 26.69B 24.28B 45.52B 3,084B 46.43B 319B 129B 1,628B 122B 120B 5,142B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.53x |
| Free-Float |
67.61% | Yield 2026 * |
1.32% | Yield 2027 * | 1.31% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DGX | Delayed | |
CBOE
| DGX | Real-time | |
|
London S.E.
| 0KSX | Delayed | |
|
Tradegate
| QDI | Real-time | |
|
Berne S.E.
| QDI | End-of-day quote | |
|
Mexican S.E.
| DGX * | End-of-day quote | |
|
Deutsche Boerse AG
| QDI | Delayed | |
|
Börse Stuttgart
| QDI | Delayed | |
|
Boerse Muenchen
| QDI | Real-time | |
|
Xetra
| QDI | Delayed | |
|
Borsa Italiana
| 1QDX | End-of-day quote |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | -0.40% | ||
| 1 week | +3.24% | ||
| Current month | -0.40% | ||
| 1 month | +7.49% | ||
| 3 months | +7.64% | ||
| 6 months | +30.18% | ||
| Current year | +44.53% |
| 1 week | 242.34 |  | 256.99 |
| 1 month | 223.5 | | 256.99 |
| Current year | 171.18 | | 256.99 |
| 1 year | 171.18 | | 256.99 |
| 3 years | 123.04 | | 256.99 |
| 5 years | 119.59 | | 256.99 |
| 10 years | 73.02 | | 256.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 2022-02-02 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 2022-07-10 |
Murali Balakumar
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 2004-11-30 |
Timothy Ring
BRD | Director/Board Member | 68 | 2011-12-06 |
James Davis
CHM | Chairman | 63 | 2023-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Free | Director | 135 | 0.0001% | ||
| 9/1/26 | Sell | Chief Executive Officer | -10,000 | 0.0091% | ||
| 8/28/26 | Exercice | General Counsel | 69,031 | 0.0625% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | +3.24% | +42.55% | +90.98% | 27.59B | |
| -1.93% | -4.34% | +13.26% | +27.10% | 113B | |
| -1.15% | +0.53% | +1.75% | +105.22% | 97.71B | |
| -8.54% | -6.42% | +90.48% | +834.45% | 54.62B | |
| +1.63% | +1.17% | -6.04% | +82.74% | 30.65B | |
| -1.60% | +7.79% | +40.02% | +73.32% | 28.87B | |
| -1.60% | -0.02% | +30.22% | +398.31% | 21.4B | |
| -1.28% | -5.38% | -21.69% | -16.69% | 19.74B | |
| -0.76% | -0.51% | -6.59% | +30.22% | 17.04B | |
| -0.94% | +12.53% | +100.48% | - | 13.81B | |
| Average | -1.64% | +0.99% | +28.44% | +180.63% | 42.46B | |
| Weighted average by Cap. | -2.09% | -0.82% | +24.14% | +182.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.08B 10.79B 9.9B 9.01B 16.88B 1,144B 17.22B 118B 47.67B 604B 45.35B 44.39B 1,907B | 12.62B 11.27B 10.34B 9.41B 17.64B 1,195B 17.99B 124B 49.79B 631B 47.37B 46.36B 1,992B |
| Net income | 1.16B 1.04B 953M 867M 1.63B 110B 1.66B 11.39B 4.59B 58.15B 4.37B 4.27B 184B | 1.24B 1.1B 1.01B 922M 1.73B 117B 1.76B 12.1B 4.88B 61.81B 4.64B 4.54B 195B |
| Net Debt | 4.99B 4.45B 4.09B 3.72B 6.97B 472B 7.11B 48.8B 19.67B 249B 18.72B 18.32B 787B | 4.34B 3.87B 3.55B 3.23B 6.06B 411B 6.18B 42.44B 17.11B 217B 16.28B 15.93B 684B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | $250.81 | -0.40% | 996,956 |
| 26-10-30 | $251.82 | -0.43% | 919,589 |
| 26-10-29 | $252.92 | +2.97% | 946,275 |
| 26-10-28 | $245.62 | +1.26% | 932,796 |
| 26-10-27 | $242.56 | -0.16% | 919,017 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
